Alteris Therapeutics - Ownership and Business Overview

Life ScienceCompany

Alteris Therapeutics Ownership

Who owns Alteris Therapeutics?

Alteris Therapeutics is owned by Celldex Therapeutics. It was acquired on October 12, 2005.

Alteris Therapeutics Business Overview

Where is Alteris Therapeutics headquartered?

Alteris Therapeutics is headquartered in Philadelphia, Pennsylvania.

How many employees does Alteris Therapeutics have?

Alteris Therapeutics has 4 employees.

What sector is Alteris Therapeutics in?

Alteris Therapeutics is a life science company.

When was Alteris Therapeutics founded?

Alteris Therapeutics was founded in 2002.

Life Science M&A Summary in 2005

Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.

Join Mergr to view all 78 acquisitions of life science companies in 2005, including 18 acquisitions by private equity firms, and 60 by strategics.

Alteris Therapeutics Inc.

416 South 10th Street,
Philadelphia, Pennsylvania 19147
United States,
(267)972-5434
www.alteristhera.com

Alteris Therapeutics, Inc. engages in the discovery and development of therapeutics and vaccines based on alternative gene splice forms for the treatment of cancer. I


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.